151 related articles for article (PubMed ID: 17598407)
1. Epidemiology of prostate cancer in the mediterranean population of Croatia--a thirty-three year retrospective study.
Spanjol J; Maricić A; Cicvarić T; Valencić M; Oguić R; Tadin T; Fuckar D; Bobinac M
Coll Antropol; 2007 Mar; 31(1):235-9. PubMed ID: 17598407
[TBL] [Abstract][Full Text] [Related]
2. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
3. A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica.
Coard KC; Skeete DH
BJU Int; 2009 Jun; 103(11):1482-6. PubMed ID: 19076136
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
Celko AM
Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
[TBL] [Abstract][Full Text] [Related]
5. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
6. [The epidemiology of prostate cancer].
Rébillard X; Tretarre B; Villers A
Rev Prat; 2003 Dec; 53(20):2224-8. PubMed ID: 15018075
[TBL] [Abstract][Full Text] [Related]
7. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000.
Mullan RJ; Jacobsen SJ; Bergstralh EJ; Slezak JM; Tindall DJ; Lieber MM; Roberts RO
BJU Int; 2005 May; 95(7):951-5. PubMed ID: 15839911
[TBL] [Abstract][Full Text] [Related]
8. Mass screening for prostate cancer in Korea: a population based study.
Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY;
J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541
[TBL] [Abstract][Full Text] [Related]
9. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
Kranjcević K; Marković BB
Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
[TBL] [Abstract][Full Text] [Related]
10. [Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].
Grosclaude P; Menegoz F; Schaffer P; Macé Lesec'h J; Arveux P; Le Mab G; Soulié M; Villers A
Prog Urol; 1997 Sep; 7(4):647-54. PubMed ID: 9410328
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of prostate cancer risk in candidates for inguinal hernia repair.
Thomas AA; Rosenblatt S; Wachterman J; Liao W; Moussa A; Ponsky LE; Jones JS
J Am Coll Surg; 2009 Sep; 209(3):371-6. PubMed ID: 19717042
[TBL] [Abstract][Full Text] [Related]
13. [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan].
Nakata S; Ohtake N; Kubota Y; Ito K; Suzuki K; Yamanaka H;
Hinyokika Kiyo; 2004 Mar; 50(3):165-70. PubMed ID: 15148767
[TBL] [Abstract][Full Text] [Related]
14. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
Loeb S; Roehl KA; Nadler RB; Yu X; Catalona WJ
J Urol; 2007 Dec; 178(6):2348-52; discussion 2352-3. PubMed ID: 17936844
[TBL] [Abstract][Full Text] [Related]
15. PSA testing in Austria: induced morbidity and saved mortality.
Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
[TBL] [Abstract][Full Text] [Related]
16. Geographical variation in incidence of prostate cancer in Sweden.
Stattin P; Johansson R; Lodnert R; Andrén O; Bill-Axelsson A; Bratt O; Damber JE; Hellström M; Hugosson J; Lundgren R; Törnblom M; Varenhorst E; Johansson JE
Scand J Urol Nephrol; 2005; 39(5):372-9. PubMed ID: 16257838
[TBL] [Abstract][Full Text] [Related]
17. Role of screening in detection of clinically localized prostate cancer.
Galić J; Karner I; Cenan L; Tucak A; Vranjes Z; Bilandzija-Peranović M; Hegedus I
Coll Antropol; 2003; 27 Suppl 1():49-54. PubMed ID: 12955891
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer risk assessment program: a 10-year update of cancer detection.
Giri VN; Beebe-Dimmer J; Buyyounouski M; Konski A; Feigenberg SJ; Uzzo RG; Hanks G; Godwin AK; Chen DY; Gordon R; Cescon T; Raysor S; Watkins-Bruner D
J Urol; 2007 Nov; 178(5):1920-4; discussion 1924. PubMed ID: 17868726
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology and clinical features of prostate cancer in Japan].
Kakehi Y
Nihon Rinsho; 1998 Aug; 56(8):1969-73. PubMed ID: 9750489
[TBL] [Abstract][Full Text] [Related]
20. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
